Drug Discovery World

AUGUST 22, 2023

Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost.

Production 52

Production Bioequivalency In-Vivo In-Vitro 52

World of DTC Marketing

APRIL 21, 2021

The amount of money Pfizer is going to make from their vaccine borders on obscene while PBMs quietly take a cut of every Rx transaction without really adding any value. And we thought developing these vaccines was all about helping people during the pandemic. Pharma is a big business. A Humana Inc.

Vaccination 273

Vaccination Vaccine Pharmacy Pharma Companies 273

FDA Law Blog

JUNE 2, 2023

Kirschenbaum — Last Friday, May 26, CMS published in the Federal Register an assortment of proposals to change the regulations governing the Medicaid Drug Rebate Program. Most are new or revised definitions and administrative changes, but several proposals represent new policies that should be of concern to drug manufacturers.

Drugs 59

Drugs Manufacturing Regulation Vaccination 59

FDA Law Blog

DECEMBER 3, 2023

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). We do not address the technical and administrative details of the Discount Program here.

Manufacturing 105

Manufacturing Drugs Compliance Pharmacy 105

Pharmacy Checkers

DECEMBER 12, 2019

The first sentence is something you are supposed to take at face value. Opponents of Americans buying less expensive drugs from overseas pharmacies (i.e. personal importation) often rely on the common belief that the U.S. Food and Drug Administration exemplifies the “gold standard” in drug safety.

Drugs 71

Drugs Manufacturing Medicine Compliance 71

The Pharma Data

MAY 14, 2021

Click here to get Hair Loss Black Book – Stop Hair Loss & Re-Grow Your Hair at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. But I understand. When people look at you, all they see is thinning hair.

Production 52

Production Hormones Doctors Doctor 52

The Pharma Data

MAY 13, 2021

Click here to get Let's Quit Sugar With Audiobook – Let's Quit Sugar at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. Learn all about how not to fall into their traps.

Insulin 52

Insulin Production Hormones Medicine 52

The Pharma Data

DECEMBER 30, 2020

But further confusing the issue was that about 1800 participants accidentally received a first dose that was only about half the intended dose. But further confusing the issue was that about 1800 participants accidentally received a first dose that was only about half the intended dose. Now that in the U.S.

Vaccination 52

Vaccination Vaccine Gene Therapy Trials 52

Pharmaceutical Technology

MAY 24, 2023

The US Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) have announced steps to push down prescription drug prices under Medicaid as part of a new proposal. It specifically seeks to improve the Medicaid Drug Rebate Program (MDRP).

Drugs 130

Drugs Manufacturing Branding Vaccination 130

Pharmaceutical Technology

DECEMBER 4, 2022

but] for biosimilars, it is all about the money. It is all about what you can get at the lowest cost,” says Dr. Raymond Cross, director of the inflammatory bowel disease program at University of Maryland’s School of Medicine, Baltimore. For a new mechanism, [being] first and second to market is important.…[but]

Marketing 262

Marketing Pharmacy Production Branding 262

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. Throughout 2022, Novartis was at the opposing ends of legal cases. Gilenya legal drama.

Doctors 242

Doctors Doctor Drugs Sales 242

Pharma Marketing Network

JUNE 8, 2020

Thanks for coming on the podcast and if you wouldn’t mind, could tell us a little bit about yourself. That’s about 28,000 partners today just in healthcare. Well, to start, could you tell me a little bit about the Health Rosetta’s Mission and how you’re progressing towards that? Dave (HR): Sure.

HR 40

HR Marketing Doctors Doctor 40

FDA Law Blog

SEPTEMBER 13, 2021

Kirschenbaum — Despite vigorous criticism of high drug prices from the public and politicians in both parties, drug companies have largely dodged bullets on drug pricing and payment reform. The pieces of major drug pricing and payment reform are falling together. Court of Appeals (again, see our post ).

Drugs 98

Drugs Manufacturing Generic Drugs Branding 98